- METRC continues to move new studies forward
To date, METRC has conducted over 35 multicenter studies, driving advancements in orthopaedic trauma research. Currently, 8 studies are ongoing, 6 are in analysis, and 21 are complete. With dozens of grant applications submitted annually, METRC continues to expand its research portfolio, building on past findings to shape the future. This ongoing work reflects the consortium’s growth, collaboration, and scientific leadership.
- Nearly 25,000 Patients
Since 2012, METRC has collaborated with over 80 trauma centers and engaged nearly 25,000 patients in close to three dozen studies, driving transformative research in orthopaedic trauma care.
- Annual and Cumulative Publications
METRC’s publication output continues to expand, reflecting the consortium’s growing impact on orthopaedic trauma research. Each year, METRC delivers dozens of podium presentations at leading conferences, including the Orthopaedic Trauma Association (OTA) Annual Meeting, the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, and the Military Health System Research Symposium (MHSRS). As new study results emerge and secondary and tertiary analyses from completed trials are published, the volume of METRC’s contributions continues to accelerate. With an undeniable presence at these key meetings, METRC remains at the forefront of advancing evidence-based trauma care.
Featured Achievement
METRC accepts The Clinical Research Forum’s Top 10 Clinical Research Achievement Award for the PREVENT CLOT study
In addition, PREVENT CLOT won a further honor, the Distinguished Clinical Research Achievement Awards
- Read more
Featured achievement
Kappa Delta Elizabeth Winston Lanier Award
Major Extremity Trauma Research Consortium Receives Prestigious Award for Advancing the Field of Clinical Trials in Trauma Orthopaedics.
- Read more
Featured Achievement
METRC Secondary Paper from Prevent Clot Study Wins Prestigious Bovill Award at OTA 2024
METRC is proud to announce that a secondary analysis from the Prevent Clot study has been awarded the Edwin G. Bovill, Jr. MD Award at the 2024 Orthopaedic Trauma Association (OTA) Annual Meeting. This distinguished honor is presented annually to the most outstanding scientific paper at the meeting, recognizing research that significantly advances the field of orthopaedic trauma.
- Read More
Featured Achievement
METRC Paper Recognized as one of 'The 24 Hottest Articles of 2024' by The Journal of Trauma and Acute Care Surgery
METRC is pleased to announce that a secondary analysis from the Prevent Clot study has been recognized as one of the "24 Hottest Articles of 2024" by the Journal of Trauma and Acute Care Surgery (JTACS). This distinction highlights research that has generated significant interest and engagement within the trauma and acute care community, reinforcing METRC’s role in advancing evidence-based approaches to thromboprophylaxis in orthopaedic trauma patients.
- Read More